.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Cerilliant
Chubb
Fuji
AstraZeneca
Queensland Health
McKesson
UBS
Harvard Business School
Citi

Generated: September 19, 2017

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-nine approved drugs.

There are two tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Applicant: Actavis Labs Fl Inc

Patents:0
Tradenames:54
Ingredients:52
NDAs:69
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
VALGANCICLOVIR HYDROCHLORIDE
valganciclovir hydrochloride
FOR SOLUTION;ORAL205220-001Jul 18, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL076179-001Feb 20, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
MIRTAZAPINE
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL076307-002Dec 17, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
GLIMEPIRIDE
glimepiride
TABLET;ORAL076995-002Apr 27, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL076620-002Oct 15, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
LEVETIRACETAM
levetiracetam
TABLET;ORAL077408-002Mar 2, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
BUPROPION HYDROCHLORIDE
bupropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL079095-001Mar 24, 2009AB1RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
KETOPROFEN
ketoprofen
CAPSULE, EXTENDED RELEASE;ORAL075270-001Mar 24, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-002Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
RAMELTEON
ramelteon
TABLET;ORAL091610-001Aug 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ACTAVIS LABS FL INC drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cipla
Colorcon
Moodys
Federal Trade Commission
QuintilesIMS
Mallinckrodt
Deloitte
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot